Pregelatinized Starch IR Granules are pharmaceutical-grade granules developed for immediate-release (IR) oral formulation applications. Pregelatinized Starch is produced by chemically and/or mechanically processing starch in the presence of water to rupture all or part of the original starch granules, followed by drying. Some types of Pregelatinized Starch may also be modified to improve their flow and compressibility characteristics.
The IR designation refers to the intended immediate-release performance of the finished granule or formulation. The actual release behavior depends on the complete formulation, granule characteristics, processing conditions, and other pharmaceutical excipients used in the final dosage form.
Pregelatinized Starch is an established pharmaceutical excipient used in oral solid formulation development. The pregelatinization process changes the physical characteristics of starch and can provide useful functional properties for pharmaceutical manufacturing.
Pregelatinized Starch may contribute to properties such as binding, filling, flow and disintegration depending on the specific grade and formulation. Its performance can vary according to starch source, processing conditions, moisture, particle characteristics and formulation composition. USP emphasizes that excipient performance can depend on material attributes and the specific formulation and manufacturing process.
For this reason, Pregelatinized Starch IR Granules should be evaluated according to their actual product specification and intended formulation application.
Immediate-release formulations are designed to provide relatively rapid availability of the incorporated component without an intentionally prolonged or delayed-release mechanism.
Research involving pregelatinized potato starch has investigated its physicochemical and excipient properties in immediate-release tablet formulations. The study reported that native, pregelatinized and modified potato starches could be useful for manufacturing immediate-release formulations.
Therefore, Pregelatinized Starch IR Granules can be considered for formulation systems where a pregelatinized starch-based pharmaceutical excipient is required for immediate-release oral solid dosage forms.
The actual dissolution and disintegration performance should always be demonstrated using the finished formulation rather than assumed from the excipient name alone.
Pregelatinized Starch IR Granules can be considered for tablet formulation development where a starch-based excipient with suitable processing and functional characteristics is required.
Depending on the grade and formulation, pregelatinized starch may contribute to binding, filling and disintegration. A recent review of starch-based pharmaceutical excipients describes starch and modified starch materials as useful in applications including binding, filling and disintegration.
During immediate-release tablet development, relevant performance attributes may include:
The final acceptance criteria should be established according to the actual formulation and approved product specification.
The immediate-release performance of Pregelatinized Starch IR Granules depends on the complete formulation and dosage form.
Factors that can influence release include:
Specific dissolution percentages or release times should not be presented as universal specifications. They should be supported by actual validated dissolution data for the finished product.
The physical properties of the finished granules are important for pharmaceutical processing and formulation performance.
Relevant characteristics may include:
These parameters are product-specific. Numerical limits should only be stated when supported by the actual approved product specification or Certificate of Analysis.
Pregelatinization alters the structure and water-interaction properties of starch. The process involves disruption of all or part of the original starch granules in the presence of water followed by drying.
The resulting material can exhibit different hydration and swelling characteristics compared with native starch. These properties can influence tablet disintegration and dissolution in suitable formulations.
For Pregelatinized Starch IR Granules, the contribution to disintegration should be evaluated in the complete formulation because tablet composition, compression conditions and other excipients can significantly influence the final performance.
Pregelatinized Starch IR Granules may be considered for a variety of oral solid formulation applications, including:
The exact function of the material depends on its grade and the requirements of the final formulation.
Quality control should distinguish between the Pregelatinized Starch raw material and the finished Pregelatinized Starch IR Granules.
Potential quality attributes include:
USP's excipient-performance guidance explains that excipient properties can influence the critical quality attributes of the finished formulation and that some performance-related properties may not be included in basic compendial specifications.
Therefore, finished Pregelatinized Starch IR Granules should be controlled according to an approved product specification appropriate for their intended application.
A Pregelatinized Starch IR Granules Manufacturer in India can develop pharmaceutical-grade granules intended for immediate-release formulation applications.
Product development may consider the starch source, pregelatinization process, drying conditions, particle-size distribution, moisture, density, flowability and formulation performance.
Consistent control of physical characteristics can support reproducible blending, filling, compression and dosage-form performance.
Pregelatinized Starch IR Granules can be supplied for pharmaceutical formulation development and oral solid dosage-form manufacturing.
A Pregelatinized Starch IR Granules Supplier in India should provide material according to the applicable product specification and quality requirements, with relevant physical and functional characteristics controlled for the intended application.
The actual immediate-release performance should be established using the finished formulation and appropriate disintegration and dissolution testing.
Pregelatinized Starch IR Granules may be considered for:
The exact function and concentration should be determined through formulation development.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white granules |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 95.0% – 105.0% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.1% |
| Heavy Metals | NMT 10 ppm |